2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
23
Breast Neoplasms
11
Prostatic Neoplasms
10
Stomach Neoplasms
7
Carcinoma, Hepatocellular
6
Small Cell Lung Carcinoma
4
Melanoma
4
Lymphoma
4
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Multiple Pulmonary Nodules
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Disease
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Smoking Cessation
2
Smoking
2
Sarcopenia
2
Recurrence
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
Gemcitabine
6
130-nm albumin-bound paclitaxel
4
S 1 (combination)
2
Radiosurgery
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Electroporation
2
zimberelimab
1
surufatinib
1
Tomography, X-Ray Computed
1
Pancreatectomy
1
Irinotecan
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Endoscopy
1
Drug Therapy
1
Diagnostic Imaging
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Pancreatic Cancer
×
Tomography, X-Ray Computed
×
Clear all
NCT06944587
2025-04-25
NORPACT-3
Oslo University Hospital
Recruiting
400 enrolled